SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-22-022449
Filing Date
2022-06-09
Accepted
2022-06-09 14:52:54
Documents
1
Group Members
WHITEBOX GENERAL PARTNER LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G brhc10038626_sc13g.htm SC 13G 89018
  Complete submission text file 0001140361-22-022449.txt   90803
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 221005696
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3033 EXCELSIOR BLVD. SUITE 500 MINNEAPOLIS MN 55416
Business Address 3033 EXCELSIOR BLVD. SUITE 500 MINNEAPOLIS MN 55416 612-253-6001
WHITEBOX ADVISORS LLC (Filed by) CIK: 0001257391 (see all company filings)

IRS No.: 411957584 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G